Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment

BACKGROUND: Photodynamic therapy (PDT) is a treatment modality for a range of diseases including cancer. The BF(2)-chelated tetraaryl-azadipyrromethenes (ADPMs) are an emerging class of non-porphyrin PDT agent, which have previously shown excellent photochemical and photophysical properties for ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne, A T, O'Connor, A E, Hall, M, Murtagh, J, O'Neill, K, Curran, K M, Mongrain, K, Rousseau, J A, Lecomte, R, McGee, S, Callanan, J J, O'Shea, D F, Gallagher, W M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778519/
https://www.ncbi.nlm.nih.gov/pubmed/19826417
http://dx.doi.org/10.1038/sj.bjc.6605247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778519/
https://www.ncbi.nlm.nih.gov/pubmed/19826417
http://dx.doi.org/10.1038/sj.bjc.6605247

Ejemplares similares